E

Entrada Therapeutics

125 employees

Entrada Therapeutics is a developer of novel therapeutics intended to treat devastating diseases.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Emergency Medicine
Genetics
Medical

Date founded

2016

Funding rounds raised

Total raised

$116M

from 10 investors over 10 rounds

E

Entrada Therapeutics raised $116M on March 31, 2021

Investors: Qatar Investment Authority, TCG X, Greenspring Associates, Point72 Ventures, MPM Capital, Redmile Group and Wellington Management

E

Entrada Therapeutics raised $59M on December 18, 2018

Investors: MPM Capital, Agent Capital and 5AM Ventures

FAQ